» Articles » PMID: 38074706

Prevalence of Intestinal Colonization and Nosocomial Infection with Carbapenem-resistant in Children: a Retrospective Study

Overview
Specialty Public Health
Date 2023 Dec 11
PMID 38074706
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We investigated the epidemiological surveillance of the intestinal colonization and nosocomial infection of carbapenem-resistant (CRE) isolates from inpatients, which can provide the basis for developing effective prevention.

Methods: A total of 96 CRE strains were collected from 1,487 fecal samples of hospitalized children between January 2016 and June 2017, which were defined as the "CRE colonization" group. In total, 70 CRE clinical isolates were also randomly selected for the comparison analysis and defined as the "CRE infection" group. The antimicrobial susceptibility of all strains was determined by the microdilution broth method. Polymerase chain reaction (PCR) was used to analyze carbapenemase genes, plasmid typing, and integrons. Multilocus sequence typing was further used to determine clonal relatedness.

Results: In the "CRE colonization" group, was mostly detected with a rate of 42.7% (41/96), followed by (34.4%, 33/96) and (15.6%, 15/96). The ST11 KPC-2 producer, ST8 NDM-5 producer, and ST45 NDM-1 producer were commonly present in carbapenem-resistant (CRKPN), carbapenem-resistant (CRECO), and carbapenem-resistant (CRECL) isolates, respectively. In the "CRE infection" group, 70% (49/70) of strains were , with 21.4% (15/70) and 5.7% (4/70). The ST15 OXA-232 producer and ST48 NDM-5 producer were frequently observed in CRKPN isolates, while the majority of NDM-1-producing CRECL isolates were assigned as ST45. Phylogenetic analysis showed that partial CRE isolates from intestinal colonization and nosocomial infection were closely related, especially for ST11 KPC-2-producing CRKPN and ST45 NDM-1-producing CRECL. Furthermore, plasmid typing demonstrated that IncF and IncFIB were the most prevalent plasmids in KPC-2 producers, while IncX3/IncX2 and ColE were widely spread in NDM producer and OXA-232 producer, respectively. Then, class 1 integron intergrase was positive in 74.0% (71/96) of the "CRE colonization" group and 52.9% (37/70) of the "CRE infection" group.

Conclusion: This study revealed that CRE strains from intestinal colonization and nosocomial infection showed a partial correlation in the prevalence of CRE, especially for ST11 KPC-2-producing CRKPN and ST45 NDM-1-producing CRECL. Therefore, before admission, long-term active screening of rectal colonization of CRE isolates should be emphasized.

Citing Articles

The pivotal role of IncFIB(Mar) plasmid in the emergence and spread of hypervirulent carbapenem-resistant .

Sun Z, Zhang J, Wang C, Chen J, Li P, Su J Sci Adv. 2025; 11(5):eado9097.

PMID: 39888998 PMC: 11784837. DOI: 10.1126/sciadv.ado9097.

References
1.
Ariyoshi T, Aoki K, Kubota H, Sadamasu K, Ishii Y, Tateda K . Molecular Characterization of -Carrying IncX3 Plasmids: Likely Emerged from a Mutation of on IncX3 Plasmid. Microbiol Spectr. 2022; 10(4):e0144922. PMC: 9430178. DOI: 10.1128/spectrum.01449-22. View

2.
Zeng G, Pang Y, Zheng J, Zhuo C, Guo Y, Liang J . Colonization with Carbapenem-Resistant Contributes to Unfavorable Outcomes in End-Stage Liver Disease Patients. Antibiotics (Basel). 2022; 11(11). PMC: 9686982. DOI: 10.3390/antibiotics11111667. View

3.
Rui Y, Lu W, Li S, Cheng C, Sun J, Yang Q . Integrons and insertion sequence common region 1 (ISCR1) of carbapenem-non-susceptible Gram-negative bacilli in fecal specimens from 5000 patients in southern China. Int J Antimicrob Agents. 2018; 52(5):571-576. DOI: 10.1016/j.ijantimicag.2018.06.015. View

4.
Magobo R, Ismail H, Lowe M, Strasheim W, Mogokotleng R, Perovic O . Outbreak of NDM-1- and OXA-181-Producing Klebsiella pneumoniae Bloodstream Infections in a Neonatal Unit, South Africa. Emerg Infect Dis. 2023; 29(8):1531-1539. PMC: 10370860. DOI: 10.3201/eid2908.230484. View

5.
Zeng M, Xia J, Zong Z, Shi Y, Ni Y, Hu F . Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. J Microbiol Immunol Infect. 2023; 56(4):653-671. DOI: 10.1016/j.jmii.2023.01.017. View